Exendin-4 ameliorates diabetic symptoms through activation of glucokinase

Journal of Diabetes
Nirav DhaneshaMukul Jain

Abstract

Glucagon-like peptide-1 (GLP-1) and its stable analogue exendin-4 maintain glucose homeostasis by modulating insulin secretion from pancreatic β-cells and controlling hepatic glucose output. Glucokinase (GK), by catalysing the first step in glycolysis, plays an important role in glucose-stimulated insulin secretion and hepatic glucose metabolism. In the present study, we investigated the effects of exendin-4 on GK in high fat-fed and alloxan-treated diabetic mice. The effects of alloxan (5, 10 and 20 μmol/L) on insulin release from isolated murine islets, as well as glycogen synthesis by isolated murine hepatocytes, were assessed. The effects of exendin-4 (10 nmol/kg, twice daily for 4 weeks) were assessed in high fat-fed, alloxan (50 mg/kg, i.v.)-treated C57 mice. Glucokinase activity was assessed in the same model. Pretreatment with exendin-4 attenuated alloxan-induced decreases in insulin release and glycogen synthesis in islets and hepatocytes. The alloxan-induced decrease in the GK activity in islets and hepatocytes was also ameliorated by exendin-4 treatment. Pretreatment with the GLP-1 receptor antagonist exendin-9 (100 nmol/L) blocked the effects of exendin-4 on the liver and pancreas. Treatment of high-fat fed, alloxan...Continue Reading

References

Jun 1, 1978·Endocrinology·D C WeaverP E Lacy
Nov 1, 1986·Chemical & Pharmaceutical Bulletin·H HaraJ Okuda
Nov 1, 1973·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·R Gunnarsson, C Hellerström
Apr 1, 1974·Analytical Biochemistry·K L Roehrig, J B Allred
Nov 15, 1982·The Biochemical Journal·F K GorusD G Pipeleers
Dec 22, 1999·Endocrine Reviews·T J Kieffer, J F Habener
Jul 26, 2002·Life Sciences·Sabine Schulte im WaldeHelga Gleichmann
Mar 18, 2004·American Journal of Physiology. Endocrinology and Metabolism·D DardevetA D Cherrington
Dec 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiaokun DingFrank A Anania
Mar 7, 2006·Cell Metabolism·Daniel J Drucker
Sep 5, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xuemei ZhangHuanran Tan
Jan 30, 2010·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yu-Kyung KimDae-Kyu Song
Apr 2, 2011·The Journal of Biological Chemistry·Shi-Ying DingMegan A Rizzo
May 15, 2012·Pharmacological Reports : PR·Nirav DhaneshaMukul Jain

❮ Previous
Next ❯

Citations

Nov 3, 2015·Peptides·Flavio FranciniJuan José Gagliardino
May 16, 2013·American Journal of Physiology. Endocrinology and Metabolism·Dale S EdgertonAlan D Cherrington
Jan 8, 2021·Journal of Ethnopharmacology·Fatma A MoharramDoaa G El-Hosari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.